These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32875598)

  • 21. Prostaglandin D
    Gupta A; Chander Chiang K
    Med Hypotheses; 2020 Oct; 143():110122. PubMed ID: 32759007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.
    Peng X; Ouyang J; Isnard S; Lin J; Fombuena B; Zhu B; Routy JP
    Front Immunol; 2020; 11():596631. PubMed ID: 33384690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach.
    Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M
    Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
    Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
    Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A
    Front Immunol; 2020; 11():1714. PubMed ID: 32793244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.
    Seydoux E; Homad LJ; MacCamy AJ; Parks KR; Hurlburt NK; Jennewein MF; Akins NR; Stuart AB; Wan YH; Feng J; Whaley RE; Singh S; Boeckh M; Cohen KW; McElrath MJ; Englund JA; Chu HY; Pancera M; McGuire AT; Stamatatos L
    Immunity; 2020 Jul; 53(1):98-105.e5. PubMed ID: 32561270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?
    Abassi Z; Knaney Y; Karram T; Heyman SN
    Front Immunol; 2020; 11():1312. PubMed ID: 32582222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.
    Parrill A; Tsao T; Dong V; Huy NT
    J Microbiol Immunol Infect; 2021 Feb; 54(1):105-108. PubMed ID: 32943328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II induces reactive oxygen species, DNA damage, and T-cell apoptosis in severe COVID-19.
    Kundura L; Gimenez S; Cezar R; André S; Younas M; Lin YL; Portalès P; Lozano C; Boulle C; Reynes J; Vincent T; Mettling C; Pasero P; Muller L; Lefrant JY; Roger C; Claret PG; Duvnjak S; Loubet P; Sotto A; Tran TA; Estaquier J; Corbeau P
    J Allergy Clin Immunol; 2022 Sep; 150(3):594-603.e2. PubMed ID: 35841981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Immune Response and Effectiveness of COVID-19 Therapies.
    Tavasolian F; Hatam GR; Mosawi SH; Saadi MI; Abdollahi E; Jamialahmadi T; Sathyapalan T; Sahebkar A
    Adv Exp Med Biol; 2021; 1321():115-126. PubMed ID: 33656718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients.
    Martín-Sánchez E; Garcés JJ; Maia C; Inogés S; López-Díaz de Cerio A; Carmona-Torre F; Marin-Oto M; Alegre F; Molano E; Fernandez-Alonso M; Perez C; Botta C; Zabaleta A; Alcaide AB; Landecho MF; Rua M; Pérez-Warnisher T; Blanco L; Sarvide S; Vilas-Zornoza A; Alignani D; Moreno C; Pineda I; Sogbe M; Argemi J; Paiva B; Yuste JR
    Front Immunol; 2021; 12():659018. PubMed ID: 34012444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease.
    Peñaloza HF; Lee JS; Ray P
    PLoS Pathog; 2021 Sep; 17(9):e1009850. PubMed ID: 34473802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 pneumonia-receptor binding and lung immunopathology: a narrative review.
    Menezes MCS; Pestana DVS; Gameiro GR; da Silva LFF; Baron Ė; Rouby JJ; Auler JOC
    Crit Care; 2021 Feb; 25(1):53. PubMed ID: 33557908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.
    Balz K; Kaushik A; Chen M; Cemic F; Heger V; Renz H; Nadeau K; Skevaki C
    Sci Rep; 2021 Feb; 11(1):4792. PubMed ID: 33637823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy Hijacking in PBMC From COVID-19 Patients Results in Lymphopenia.
    Barbati C; Celia AI; Colasanti T; Vomero M; Speziali M; Putro E; Buoncuore G; Savino F; Colafrancesco S; Ucci FM; Ciancarella C; Balbinot E; Scarpa S; Natalucci F; Pellegrino G; Ceccarelli F; Spinelli FR; Mastroianni CM; Conti F; Alessandri C
    Front Immunol; 2022; 13():903498. PubMed ID: 35711451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patients.
    Huang X; Kantonen J; Nowlan K; Nguyen NA; Jokiranta ST; Kuivanen S; Heikkilä N; Mahzabin S; Kantele A; Vapalahti O; Myllykangas L; Heinonen S; Mäyränpää MI; Strandin T; Kekäläinen E
    Virus Res; 2024 Mar; 341():199315. PubMed ID: 38211733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiologically Undetectable Latent Pulmonary Lymphocyte Infiltration Suggesting the Need for Early Glucocorticoid Therapy: An Autopsy Case of Rapidly Progressive COVID-19 Pneumonia with Lymphopenia.
    Tanomogi N; Otani T; Araki J; Sugitani A; Itagaki S; Kiriu T; Shimada K
    Intern Med; 2021 Jul; 60(13):2145-2148. PubMed ID: 33994439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences.
    Alshammary AF; Al-Sulaiman AM
    Virulence; 2021 Dec; 12(1):1771-1794. PubMed ID: 34251989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.